Royce & Associates LP Has $28.69 Million Stock Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Royce & Associates LP boosted its position in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 157.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 273,671 shares of the semiconductor company's stock after purchasing an additional 167,235 shares during the quarter. Royce & Associates LP owned about 0.84% of Axcelis Technologies worth $28,694,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Signaturefd LLC increased its holdings in shares of Axcelis Technologies by 348.9% during the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company's stock valued at $30,000 after purchasing an additional 164 shares during the period. Blue Trust Inc. increased its stake in Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company's stock valued at $39,000 after buying an additional 188 shares during the period. Ashton Thomas Private Wealth LLC bought a new stake in shares of Axcelis Technologies during the 2nd quarter worth about $39,000. Isthmus Partners LLC boosted its holdings in shares of Axcelis Technologies by 87.3% in the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company's stock valued at $47,000 after acquiring an additional 15,507 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in shares of Axcelis Technologies during the second quarter valued at approximately $69,000. 89.98% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Trading Down 7.1 %

Shares of NASDAQ ACLS traded down $5.63 during mid-day trading on Friday, hitting $73.22. 1,003,666 shares of the company traded hands, compared to its average volume of 634,544. The business has a 50 day moving average of $94.75 and a two-hundred day moving average of $112.42. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of 10.83, a PEG ratio of 2.46 and a beta of 1.60. Axcelis Technologies, Inc. has a 1 year low of $73.15 and a 1 year high of $158.61. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04.

Analyst Ratings Changes

A number of research firms have weighed in on ACLS. Needham & Company LLC restated a "hold" rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Benchmark cut Axcelis Technologies from a "buy" rating to a "hold" rating in a research note on Friday, November 8th. Finally, B. Riley lowered their target price on Axcelis Technologies from $190.00 to $165.00 and set a "buy" rating on the stock in a report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.